Korea To Bolster Fast-Track System With Speedier Drug Approvals In Mind
This article was originally published in SRA
Executive Summary
South Korea plans to draw up detailed guidelines for a fast-track drug review and approval system this year to increase applications for such reviews, provide the pharma industry with a clearer understanding of the process, and provide timely patient access to more treatment options.